ClinVar Miner

Submissions for variant NM_006261.4(PROP1):c.109+1G>T (rs1214465435)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV000778762 SCV000915128 likely pathogenic Pituitary hormone deficiency, combined 2 2018-12-11 criteria provided, single submitter clinical testing The PROP1 c.109+1G>T variant occurs in a canonical splice site (donor) and is therefore predicted to disrupt or distort the normal gene product. The variant is reported in a compound heterozygous state in two individuals with combined pituitary hormone deficiency (Böttner et al. 2004; Madeira et al. 2017). Control data are unavailable for this variant, and it is not reported in the 1000 Genomes Project, the Exome Sequencing Project, the Exome Aggregation Consortium, or the Genome Aggregation Database. Based on the evidence and the potential impact of splice donor variants, the c.109+1G>T variant is classified as likely pathogenic for combined pituitary hormone deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.